XML 51 R40.htm IDEA: XBRL DOCUMENT v3.25.3

Note 17 - Earnings Per Share (Tables)

3 Months Ended

Sep. 30, 2025

Notes Tables

Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]

		Three Months Ended
		September 30,
		2025				2024
		(in thousands, except share and per share data)
BASIC
Numerators:
Net income from continuing operations		$	1,965			$	1,093
Net income from discontinued operations, net of tax			—				381
Net income		$	1,965			$	1,474
Denominator:
Basic weighted-average common shares outstanding			9,441,073				6,068,019
Basic per share calculations:
Net income per share from continuing operations		$	0.21			$	0.18
Net income per share from discontinued operations, net of tax		$	—			$	0.06
Net income per share		$	0.21			$	0.24

		Three Months Ended
		September 30,
		2025				2024
		(in thousands, except share and per share data)
DILUTED
Numerators:
Adjusted numerator - net loss from continuing operations (1)		$	(1,505	)		$	(1,787	)
Net income from discontinued operations, net of tax			—				381
Net loss		$	(1,505	)		$	(1,406	)
Denominator:
Basic weighted-average common shares outstanding			9,441,073				6,068,019
Dilutive effect of warrants to purchase common stock			10,035,562				3,028,862
Dilutive effect of options to purchase common stock			—				2,720
Diluted weighted-average common shares outstanding			19,476,635				9,099,601
Diluted per share calculations:
Net loss per share from continuing operations		$	(0.08	)		$	(0.20	)
Net income per share from discontinued operations, net of tax		$	—			$	0.04
Net loss per share		$	(0.08	)		$	(0.15	)

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]

		Three Months Ended
		September 30,
		2025				2024
Warrants to purchase common stock - liability classified (note 16)			3,144,536				455,392
Warrants to purchase common stock - equity classified (note 16)			15,571				18,114
Weighted-average of warrants exercised to common stock (note 16)			495,000				—
Outstanding stock options (note 15)			206,800				10,644
Unvested restricted stock (note 15)			31,298				1,211
Unvested restricted stock units (note 15)			—				141,439
Total anti-dilutive securities			3,893,205				626,800

X

- Definition

Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-1

+ Details

Name:	us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-1

+ Details

Name:	us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_TableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration